Amgen (AMGN) will invest an initial $200 million this year in its new technology center in southern India, Reuters reported Monday, citing Chief Executive Robert Bradway.
The US drugmaker has also planned "significant" investments for future years as part of its plan to expand its presence in India, according to the report.
By the end of the year, the site in Hyderabad city is expected to have a workforce of roughly 2,000, Reuters reported, citing Som Chattopadhyay, national executive for India at Amgen.
Amgen did not immediately respond to MT Newswires' request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.